Autologous hematopoietic stem cell transplantation vs Alemtuzumab in Multiple Sclerosis: An Italian multicenter study

Authors
Category Primary study
ConferenceThe 40th Congress of the European Committee for Treatment and Research in Multiple Sclerosis
Year 2024
This article has no abstract
Epistemonikos ID: c8e551a167ba63b5e2887561b3c00aa4cd22596e
First added on: Apr 04, 2026